budget: 16 proof points
Rows on the facts page whose own text or source section carries "budget". The product name links the page with the full text. All skills.
| Role | Product | Situation | Task | Action | Result | Year | Skills |
|---|---|---|---|---|---|---|---|
| Senior Product Manager at Novo Nordisk | Wegovycare Wegovycare, a digital service to drive retention and repeat prescriptions for Wegovy | Applied for a SaMD product role at Novo; put forward instead for a digital solution for a then unheard-of weight-loss medicine. The final-round brief was solution-first: standalone features the business thought would help. Nobody had spoken to patients. | Persuade the business to set the brief aside and start with the problem, then use that as a mandate to change how they worked. | First product team at Novo to interview patients, run discovery, build prototypes and co-create with markets. Led a cross-functional team of 10 across the full product lifecycle; it took persuasion and a leap of faith from stakeholders. | Launched on time and on budget. 10% penetration in the first national market, the biggest adoption of any digital solution at Novo; still live. Asked to scale the ways of working across the organisation and promoted to Associate Product Director. | Mar 2020 - Feb 2022 | pharma, healthcare, patients, discovery, prototyping, ways of working, growth, retention, launch, 0 to 1, team leadership, stakeholders, budget |
| Associate Product Director at Novo Nordisk (contributed, one of a team) | Wegovy Pill launch Wegovy Pill launch, consumer workstream | Pitched for and invited onto the launch team for a company-critical initiative to inject new thinking (very unusual for a digital role). Digital, packaging and direct distribution sat in separate silos, each with its own assumptions. | Lead the HQ consumer workstream. | Applied subscription-model thinking to connect the physical product to digital fulfilment: QR codes on the boxes linking to the digital experience, and work with production on bundling three boxes in a tertiary carton. | Contributed to the largest pharma launch on record. | Feb 2022 - Feb 2026 | pharma, healthcare, patients, growth, retention, launch, marketing, SaaS, team leadership, international, consumer, budget |
| Associate Product Director at Novo Nordisk | CagriSema Digital discovery programme for CagriSema, the company's top drug asset | CagriSema was the first drug to span two therapy areas, diabetes and obesity. Each business unit ran independently with their own priorities and budgets. | Define what digital initiatives should accompany the drug, get both business units to agree, and get it funded. | Started with the problem, and uncovering the new user journeys to create a shared understanding of the problem space across both units. Then ideation: 128 candidate ideas, cut to a shortlist of 5, assumption-tested with prototypes, 4 recommended, each with a funding-gated rollout. Navigated the programme through internal governance. | Funding secured for a portfolio of 4 digital initiatives (a first). Aligned two business units on a common digital strategy (also a first). | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, patients, discovery, prototyping, incubation, ways of working, growth, retention, funnels, experimentation, launch, brand, team leadership, stakeholders, consumer, budget |
| Associate Product Director at Novo Nordisk | Digital Incubation Digital incubation unit for branded digital engagement, evaluating build, buy and partner solutions | Asked after Wegovycare to scale its ways of working across the product organisation: to work across silos and help move the organisation from solution-first project thinking to a product model with an outcomes focus. | Build the unit that shapes the organisation's next big bets, and make problem-first the default. | Built the incubation unit entirely through influence. Designed a portfolio model and a gated incubation pipeline. Wrote the discovery playbook. Coached the incubation PMs. Secured funding and managed resourcing and cross-charges for the incubation teams. Evaluated build, buy and partner options for each bet. | Moved the business from solution-first to problem-first, and from output to outcomes. | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, patients, discovery, incubation, ways of working, growth, retention, funnels, experimentation, launch, brand, team leadership, stakeholders, consumer, budget |
| Associate Product Director at Novo Nordisk | Product Operations standards, artefacts, ways of working | A wider remit across the product pipeline, to complete the move to a product operating model. | Establish metrics across a portfolio of 12 products. | Set product artefacts and quality standards: gate model and deliverables, product-ops metrics, portfolio reports, business case templates, problem and north-star statements. | Helped product teams connect work to commercial outcomes. | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, patients, discovery, incubation, ways of working, growth, retention, funnels, experimentation, launch, brand, team leadership, stakeholders, consumer, budget |
| Associate Product Director at Novo Nordisk | Head of Patient Products Patient Solutions, a portfolio of consumer engagement products (companion apps adjacent to the medicines) | Interim reorg of product teams before the Wegovy Pill project. | Lead 6 experienced PMs building consumer engagement products, managing by outcomes; for a period, before moving into the pill team where the need was greatest. | Individual coaching and weekly experiment sharing; made individual product metrics public. | Broke product silos, established weekly demos and experiment sharing, encouraged learning loops. | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, patients, discovery, incubation, ways of working, growth, retention, funnels, experimentation, launch, brand, team leadership, stakeholders, consumer, budget |
| Associate Product Director at Novo Nordisk | project steercos Chaired project steercos. Flipped the format from status updates to interactive co-creation | Steercos were project management checklists: project not product focused, and unsuited for high-uncertainty discovery-stage products. | Chair project steercos. | Flipped the format from status updates to interactive co-creation. | Cross-functional VPs moved from product sceptics to advocates. | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, patients, discovery, incubation, ways of working, growth, retention, funnels, experimentation, launch, brand, team leadership, stakeholders, consumer, budget |
| PM/GM at LEO Innovation Lab | Skincoach Skincoach, a patient-support app for terminally ill cancer patients, built in partnership with Amgen | Amgen, one of the world's largest biotech companies and a leading maker of immunotherapy treatments, wanted to help patients manage the skin reactions that come with treatment. Those reactions affect quality of life and, in some cases, whether a patient can stay on treatment. Nothing existed for the time between oncologist appointments. | Build a product for this audience under strict regulatory and ethical constraints, and agree a partnership model with Amgen that neither company had used before. | Interviewed terminally ill patients and worked with oncologists to reimagine care between appointments. Every decision intentional and judged with sensitivity: no moving fast and breaking things. Dynamically spliced video to simulate personalised dermatology consultations, designed for simplicity and trust. Negotiated a new partnership model with Amgen that challenged convention. | Full product lifecycle in 8 months, on time and on budget. Live closed pilot in Spain and France. The partnership model was later adopted by Amgen's core business as an exemplar for innovation partnerships. | Feb 2018 - Oct 2018 | regulated, healthcare, patients, discovery, ways of working, growth, launch, domains, international, stakeholders, partnerships, budget |
| Head of Marketing, Opbeat | Opbeat Opbeat, developer tools SaaS startup providing application performance monitoring. Backed by the cofounders of Facebook and Instagram. | New product came out of stealth and lacked traction. The audience was developers, who are allergic to advertising. | Build the brand, marketing strategy, team and channels from scratch, and get traction without advertising at people who ignore advertising. | Learnt the developer audience by sitting with the engineers in the team. Defined the core product proposition and the developer narrative, and told the story. Built the brand, the team and the channels from nothing, then ran growth experiments across them. The two biggest levers, the meetup video engine and the pricing restructure, have their own rows. | Trebled traffic and sign-ups in 12 months. The brand became known in the Python, Django and Node.js communities. | Nov 2014 - Apr 2016 | growth, conversion, experimentation, KPIs, launch, 0 to 1, brand, marketing, SaaS, startup, developer tools, team leadership, international, budget |
| Acting Marketing Manager US, UK2 Group | US Marketing department Managed all online and marketing activity across 5 web properties | Run remotely from the UK, with a team never met in person. | Rebuild the underperforming US Marketing department before recruiting a US-based successor. | Created the marketing strategy, implemented a reporting structure, set and met budget targets. | Bounce rate down ~15%; sales conversion nearly doubled; product roadmap created and 8 products launched in 10 months. | Feb 2009 - Feb 2010 | turnaround, growth, conversion, roadmap, launch, marketing, team leadership, remote, international, budget |
| Head of Group Strategy, UK2 Group | new domain platform One platform replaced them | 6 brands on 3 different providers, some going direct to the registry, each with different APIs, rules and management fees. | Manage development of a new domain platform. | Owned the business case, budget, specifications, contracts and migration strategy. | One platform replaced them (500,000+ customer domains). | 2008-2010 | turnaround, retention, launch, brand, marketing, ecommerce, domains, web hosting, team leadership, remote, international, budget |
| Head of Marketing, Opbeat | Opbeat Opbeat, B2B devops startup backed by Balderton Capital and the cofounders of Facebook and Instagram | A small startup with no marketing processes, KPIs, reporting or budgeting, and a runway to extend. | Put the basics in and create enough traction to raise. | Introduced marketing processes, KPIs, reporting and budgeting to the business. Grew grassroots meetups and built a video engine to reach developers. | Traction that enabled a $2M bridge-funding round. | Nov 2014 - Apr 2016 | growth, conversion, KPIs, launch, 0 to 1, brand, marketing, SaaS, startup, developer tools, team leadership, international, budget |
| Head of Group Strategy, UK2 Group | Midphase pricing Midphase, UK2 Group's underperforming US hosting business unit | The US unit had a downward revenue trend: two flat-rate monthly accounts, very few customers on the top one, high churn. Tom was the CEO's troubleshooter across the UK, US and Ukraine offices, working remotely from the UK. | Diagnose the unit and reverse the trend without a new product. | Lifecycle analysis of the customer base. Restructured the two flat plans into tiered accounts with term-based pricing (3, 12 and 24 months), framed so longer commitments were visibly cheaper per month. Ran an anti-churn programme for existing customers: free upgrades to the new plans, added features such as backup to justify the structure, and switching costs such as losing the free domain on downgrade. Repositioned the brand and marketing and created a product roadmap. | ARPU up, customer lifetime extended, recurring revenue locked in. Downward revenue trend reversed in 6 months. 8 products launched in 10 months. | Sep 2008 - Sep 2010 | turnaround, retention, roadmap, launch, brand, marketing, ecommerce, domains, web hosting, team leadership, remote, international, budget |
| PM/GM at LEO Innovation Lab | Amgen partnership model Innovation partnership between LEO Innovation Lab and Amgen for Skincoach | Partnerships operated as mercenaries not missionaries. The standard contracting process was delivery to be completed (output), not outcomes. | Negotiate a partnership model that allowed building and piloting inside the constraints of two regulated companies. | Managed stakeholders on both sides and negotiated a new partnership model and ways of working. It challenged convention at the time. | The contract model and ways of working were later adopted by Amgen's core business as an exemplar for innovation partnerships. Tom led in-market discovery and delivery under it. | Feb 2018 - Oct 2018 | regulated, healthcare, patients, discovery, ways of working, growth, launch, domains, international, stakeholders, partnerships, budget |
| Head of Marketing, Opbeat | Opbeat meetup video engine Opbeat developer community channel | The audience was developers, who are allergic to advertising. Brand-building and acquisition with no budget for ads that would not have worked anyway. | Reach developers where they already were, and have them bring the audience. | Advertised for a video marketing intern to travel the world attending developer meetups, unpaid but all expenses covered. Filmed and live-streamed the meetups on the company blog; speakers promoted the stream to their own developer audiences. No direct advertising in the video; the audience captured with retargeting ads, organic traffic and backlinks. | Grassroots meetup presence and a content engine that fed the trebling of traffic and sign-ups. Scrappy, high-leverage. | Nov 2014 - Apr 2016 | growth, conversion, SEO, KPIs, launch, 0 to 1, brand, marketing, SaaS, startup, developer tools, team leadership, international, budget |
| Head of Marketing, Opbeat | Opbeat pricing Opbeat pricing and free tier | The pricing model inadvertently disincentivised upgrading, and there were barriers at the point of entry for a product that needed developers to try it first. | Remove the barriers to entry and to upgrade. | Found the disincentive in the pricing structure and persuaded the CEO to restructure it. Put the emphasis on the free tier so growth came from the ground up: developers adopt first, teams pay later. Demoted pricing from the navigation to the footer to cut friction at entry. | Pricing that no longer worked against the product's own growth loop, feeding the trebling of sign-ups. No separate figure for this lever. | Nov 2014 - Apr 2016 | growth, conversion, KPIs, launch, 0 to 1, brand, marketing, SaaS, startup, developer tools, team leadership, international, budget |